Rubinstein-Taybi syndrome 2 with cerebellar abnormality and neural tube defect.


Journal

Clinical dysmorphology
ISSN: 1473-5717
Titre abrégé: Clin Dysmorphol
Pays: England
ID NLM: 9207893

Informations de publication

Date de publication:
Jul 2019
Historique:
pubmed: 23 2 2019
medline: 18 12 2019
entrez: 22 2 2019
Statut: ppublish

Résumé

Rubinstein-Taybi syndrome (RSTS) is a rare dominant disorder with intellectual disability, postnatal growth deficiency, and multiple congenital anomalies. Approximately 50-70% of the patients have a mutation in the CREBBP gene (RSTS1) and 5-10% display an EP300 gene mutation (RSTS2). Craniospinal abnormalities such as microcranium, scoliosis, and lordosis are frequent findings in RSTS1, but malformations of the brain or spinal cord are seen only occasionally. Here, we report on a 3-year-old boy with facial abnormalities of RSTS, broad thumbs and halluces, developmental delay, autistic features, cerebellar underdevelopment, and a neural tube defect. Molecular diagnostic of the CREBBP and EP300 genes showed a heterozygous 17-bp deletion (c.5698_5714del AAGGCAGCAGGCCAGGT) in exon 31 of the EP300 gene. Findings underline that small (hypoplastic) cerebellum and neural tube defects belong to the phenotypic spectrum not only of RSTS1 but also of RSTS2. Based on the literature and this observation, we recommend that each individual with RSTS2 should be closely evaluated for neural axis and craniovertebral junction anomalies, and where appropriate, neuroimaging studies should be considered. Our frequency estimate of ~ 6% occult or overt neural tube defects in RSTS2 could represent an underestimate.

Identifiants

pubmed: 30789376
doi: 10.1097/MCD.0000000000000262
pmc: PMC6553355
doi:

Substances chimiques

CREB-Binding Protein EC 2.3.1.48
CREBBP protein, human EC 2.3.1.48
E1A-Associated p300 Protein EC 2.3.1.48
EP300 protein, human EC 2.3.1.48

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

137-141

Références

Am J Dis Child. 1963 Jun;105:588-608
pubmed: 13983033
Am J Hum Genet. 2005 Apr;76(4):572-80
pubmed: 15706485
Am J Med Genet A. 2005 Jun 1;135(2):130-3
pubmed: 15832359
Hum Genet. 2005 Sep;117(5):485-93
pubmed: 16021471
Eur J Hum Genet. 2006 Sep;14(9):981-5
pubmed: 16868563
J Neurosurg. 2006 Oct;105(4 Suppl):261-4
pubmed: 17328274
Am J Med Genet A. 2010 Jan;152A(1):181-4
pubmed: 20014264
Am J Med Genet A. 2011 Nov;155A(11):2766-70
pubmed: 21932317
Childs Nerv Syst. 2012 Dec;28(12):2163-8
pubmed: 22914921
Am J Med Genet A. 2014 Sep;164A(9):2300-9
pubmed: 24989455
PLoS One. 2015 Jul 14;10(7):e0132468
pubmed: 26171964
Neuroradiol J. 2015 Jun;28(3):238-53
pubmed: 26246090
Am J Med Genet A. 2016 Dec;170(12):3069-3082
pubmed: 27648933
Clin Dysmorphol. 2017 Jul;26(3):170-174
pubmed: 28027063
Am J Med Genet A. 2018 Apr;176(4):862-876
pubmed: 29460469
Nature. 1995 Jul 27;376(6538):348-51
pubmed: 7630403

Auteurs

Kinga Hadzsiev (K)

Department of Medical Genetics, Medical School, Clinical Center, University of Pécs, Pécs.

Zsuzsanna Gyorsok (Z)

Department of Neurology, Bethesda Children Hospital, Budapest, Hungary.

Márta Czakó (M)

Department of Medical Genetics, Medical School, Clinical Center, University of Pécs, Pécs.

Oliver Bartsch (O)

Institute of Human Genetics, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH